Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 24 OTHER 19 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 24 Radiotherapy 18 Carboplatin 18 Paclitaxel 17 Vincristine 15 Cyclophosphamide 14 Etoposide 13 Filgrastim 12 Doxorubicin 12 Gemcitabine 11 Temozolomide 10 Cytarabine 9 Topotecan 8 Docetaxel 8 Methotrexate 7 Irinotecan 7 Granulocyte Colony-Stimulating Factor 7 Dexamethasone 7 Taxes 6 Radiation 6 Peripheral Blood Stem Cell Transplantation 6 Radiotherapy, Conformal 5 Oxaliplatin 5 Melphalan 5 Fenretinide 5 Chemotherapy, Adjuvant 5 Capecitabine 5 etoposide phosphate 4 Trastuzumab 4 Platinum 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NETWORK × Afatinib × Clear all

NCT03827070 2023-04-25

DPTA

Center Trials & Treatment Europe

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡